Onychodystrophy Testing
The Standard of Care
-
Provides a comprehensive diagnosis with objective information for the identification and treatment of nail dystrophy.
-
Laboratory testing delivers information necessary to support a complete patient treatment algorithm.
-
Various nail disorders appear identical and clinical examination alone may not be enough.
Learn more about adding Onychodystrophy testing to your patient care algorithm
Complete the form below and your local sales account manager will reach out to answer your questions about BakoDx histopathology + PCR onychodystrophy testing.
Definitive Diagnosis
Laboratory testing identifies the underlying cause of nail dystrophy, infectious, non-infectious, neoplastic processes, and trauma
Complete Picture
Histopathology + PCR Testing provide comprehensive information to treat nail dystrophy effectively.
Targeted Treatment
Identifying the genus and species of the infectious organism allows you to target therapy with precision.
The Complete Picture
*When used in combination; Bako Nail PCR Testing: 99.9% Analytical Specificity, 86% Clinical Sensitivity. Bako’s PCR testing highly correlates with histopathology. Histopathology: 93% Clinical Sensitivity, 96% Clinical Specificity. Fungal culture: 42% False Negative Rates
Click image to enlarge
Histopathology
Microscopic evaluation of a specimen to determine infectious or non-infectious pathologies including traumatic, inflammatory or neoplastic processes.
Periodic Acid–Schiff (PAS): Identifies non-degenerated fungal elements
Grocott Methenamine Silver (GMS): Identifies degenerated fungal elements
Fontana-Masson (FM): Identifies pigmented saprophytes and melanin pigment which may be associated with a melanocytic neoplasm
PCR Testing
Molecular analysis of a specimen to determine if DNA of an infectious organism is present. The Onychodystrophy PCR testing identifies both the genus and species of an infectious organism to appropriately target therapy.
BakoDx offers PCR testing for onychodystrophy with 99.9% analytical specificity 86% clinical sensitivity;¹ which correlates highly with histopathology. Our proprietary technology only identifies the relevant agents of disease for you to provide targeted treatment. Learn more about adding this advanced service to your patient care algorithm.
Click image to enlarge
BakoDx’s Intelligent Onychodystrophy PCR Testing Report
Actionable reports with information to assist you in making treatment decisions.
Educational Resources for Onychodystrophy
¹BakoDx internal validation.
²Velasquez-Agudelo, V., Cardona-Arias, J., “Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis”, BMC Infect Dis, 2017 Feb 22;17(1):166.
³Chandran, N. S., J. Y. Pan, Z. A. Pramono, H. H. Tan and C. S. Seow (2013).”Complementary role of a polymerase chain reaction test in the diagnosis of onychomycosis.” Australas J Dermatol 54(2): 105-108
Disclaimer: BakoDx, as a partner to your practice, provides learning resources to help you better serve your patients. The information contained within this document should be used at a physician’s discretion. BakoDx assumes no liability for its content.